Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 25, 2026Expert Opinion on Therapeutic Targets

Structure-guided targeting of Plasmodium falciparum aminopeptidase P: exploiting S4′ dimer-interface interactions for selective antimalarial drug design

View Full Paper
Ask AI
Bookmark
Share

Authors

RIR. Elwyn IsaacGMGlenn A. McConkeyRFRichard Foster

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Isaac et al. (2026) studied this question.

synapsesocial.com/papers/6ab60fa9406bf401c1468607https://doi.org/10.1080/14728222.2026.2738351
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Hydroxamate-based inhibitors reveal structural determinants of selectivity for Plasmodium falciparum aminopeptidase P2026
  2. 2Aminopeptidase Inhibition in Drug‐Resistant <i>Plasmodium falciparum</i> : Structural, Functional, and Pharmacological Rationale for Targeting PfA‐M1 and PfA‐M172026
  3. 3Analysing the essential proteins set of Plasmodium falciparum PF3D7 for novel drug targets identification against malaria2021 · 27 citations
  4. 4Targeting proteolytic enzymes in the hemoglobin degradation pathway to inhibit Plasmodium falciparum: An in silico approach2025
  5. 5Optimization of species-selective reversible proteasome inhibitors for the treatment of malaria2025